Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (391-400 of 519) with videos related to

Pageof 52
Sort By:
Biological Psychiatry|April 18, 2002
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposureRalph W Kupka, Willem A Nolen, Robert M Post, et al.
Biological Psychiatry|July 4, 2006
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderPaul E Keck, Jim Mintz, Susan L McElroy, et al.
Frontiers in Psychiatry|September 21, 2023
Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal studyManuel Gardea-Resendez, Javier Ortiz-Orendain, Alessandro Miola, et al.
Bipolar Disorders|February 27, 2026
SGLT2 Inhibitors Associated With Improved Kidney Function in Lithium-Treated Patients With Mood Disorders: A Real-World Historical Cohort StudyMete Ercis, Idil Tarikogullari, Vanessa K Pazdernik, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Sodium-Glucose Cotransporter 2 Inhibitors for Lithium-Associated Kidney Dysfunction in Mood Disorders: A Real-World Historical Cohort StudyMete Ercis, Idil Tarikogullari, Vanessa K Pazdernik, et al.
Frontiers in Pharmacology|September 19, 2022
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorderMing-Fen Ho, Cheng Zhang, Irene Moon, et al.
Journal of Affective Disorders|December 20, 2015
Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorderSusan L McElroy, Scott Crow, Thomas J Blom, et al.
International Journal of Bipolar Disorders|February 25, 2026
The anxious bipolar phenotype: clinical complexity and treatment responseBalwinder Singh, Ada Man-Choi Ho, Brandon J Coombes, et al.
Translational Psychiatry|July 6, 2019
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatientsSudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, et al.
Molecular Psychiatry|June 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysisGustavo C Medeiros, Todd D Gould, William L Prueitt, et al.
Pageof 52

Showing results (391-400 of 519) with videos related to

Sort By:
Pageof 52
Biological Psychiatry|April 18, 2002
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposureRalph W Kupka, Willem A Nolen, Robert M Post, et al.
Biological Psychiatry|July 4, 2006
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderPaul E Keck, Jim Mintz, Susan L McElroy, et al.
Frontiers in Psychiatry|September 21, 2023
Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal studyManuel Gardea-Resendez, Javier Ortiz-Orendain, Alessandro Miola, et al.
Bipolar Disorders|February 27, 2026
SGLT2 Inhibitors Associated With Improved Kidney Function in Lithium-Treated Patients With Mood Disorders: A Real-World Historical Cohort StudyMete Ercis, Idil Tarikogullari, Vanessa K Pazdernik, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Sodium-Glucose Cotransporter 2 Inhibitors for Lithium-Associated Kidney Dysfunction in Mood Disorders: A Real-World Historical Cohort StudyMete Ercis, Idil Tarikogullari, Vanessa K Pazdernik, et al.
Frontiers in Pharmacology|September 19, 2022
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorderMing-Fen Ho, Cheng Zhang, Irene Moon, et al.
Journal of Affective Disorders|December 20, 2015
Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorderSusan L McElroy, Scott Crow, Thomas J Blom, et al.
International Journal of Bipolar Disorders|February 25, 2026
The anxious bipolar phenotype: clinical complexity and treatment responseBalwinder Singh, Ada Man-Choi Ho, Brandon J Coombes, et al.
Translational Psychiatry|July 6, 2019
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatientsSudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, et al.
Molecular Psychiatry|June 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysisGustavo C Medeiros, Todd D Gould, William L Prueitt, et al.
Pageof 52